Since globe facing patent expiry of drugs, aging population, rising demand for anti-cancer drugs, the Active Pharmaceutical Ingredients (API) Market is expected to reach $168 Billion by 2020 at a CAGR of 8.33% over 2016-2020.

In the terms of geography, North America holds largest share in Active Pharmaceutical Ingredients (API) market because it’s well established R&D infrastructure for novel drug development and increased generic medicine sales over the globe.

Asia-Pacific (APAC) holds second major share and is fastest growing market followed by Europe and Rest of the world. Emerging countries such as China, India and Italy are major contributors due to low labor and manufacturing costs, government emphasis on healthcare reforms.

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.

The global API market is segmented based on synthesis, customer base, business type and therapeutic applications. Depending on synthesis the market is classified into synthetic chemical API, biotech API and HPAPI (Highly Potent Active Pharmaceutical Ingredient). Biotech API is further segmented into mammalian cell culture, monoclonal antibodies, recombinant proteins, vaccines, insulin analog, growth hormones and interferons.

Read Full Report: http://www.gosreports.com/global-active-pharmaceutical-ingredient-api-market-research-report-2016/

Joanna | Executive – International Business and partner Relations
E-mail: [email protected] | Tel: 001-510-400-8520
Web: www.gosreports.com
________________________________________________